0001875179-22-000001.txt : 20220207 0001875179-22-000001.hdr.sgml : 20220207 20220207154524 ACCESSION NUMBER: 0001875179-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220207 DATE AS OF CHANGE: 20220207 EFFECTIVENESS DATE: 20220207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Avalo, Inc. CENTRAL INDEX KEY: 0001875179 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-432631 FILM NUMBER: 22597288 BUSINESS ADDRESS: STREET 1: 1501 HOLLYWOOD STREET CITY: DURHAM STATE: NC ZIP: 27701 BUSINESS PHONE: 919-627-8065 MAIL ADDRESS: STREET 1: 1501 HOLLYWOOD STREET CITY: DURHAM STATE: NC ZIP: 27701 D 1 primary_doc.xml X0708 D LIVE 0001875179 Avalo, Inc. 1501 HOLLYWOOD STREET DURHAM NC NORTH CAROLINA 27701 919-627-8065 DELAWARE None None Corporation true 2020 Brendan Collins 1501 Hollywood Street Durham NC NORTH CAROLINA 27701 Executive Officer Director Promoter Mariano Alvarez 1501 Hollywood Street Durham NC NORTH CAROLINA 27701 Executive Officer Director Promoter Laurie Menoud 1501 Hollywood Street Durham NC NORTH CAROLINA 27701 Director Biotechnology Decline to Disclose 06b false 2021-12-31 false true true false 0 1100000 500000 600000 false 2 0 0 0 true Proceeds will be used for working capital, which may include normal compensation to executive officers. false Avalo, Inc. Brendan Collins Brendan Collins CEO 2022-02-01